Hepatitis B market on hot competition

Published: 2010-07-01 06:59:00
Updated: 2010-07-01 06:59:00
30-odd Korean companies are going to launch a generic version of Hepsera (adefovir dipivoxil) in July, thus shedding a red light on its competitive market.

Dosed as one oral 10 mg tablet, once daily, adefovir dipivoxil belongs to a novel class of drugs called nucleotide analogues, which are de...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.